[ORGANIZATION]
Guselkumab
Featured in 1 tracked story · first seen
Situations
Guselkumab reimbursement approval in Italy
2 clusters · 13 sources · last updated
Latest: Italy approves reimbursement for Guselkumab for bowel diseases
Italy has approved reimbursement for the Johnson & Johnson drug guselkumab (Tremfya) to treat two specific inflammatory bowel diseases: moderate to severe active ulcerative colitis and moderate to severe active Crohn’s d